Zdrowie i gospodarka · 21/03/2018

FDA Releases Draft Guidance on Postmarketing Safety Reporting for Combination Products

The Food and Drug Administration (FDA) has made available a draft guidance document outlining the agency's expectations for postmarketing safety reporting of combination products, which are medical products composed of two or more different types of products, including drugs, devices, and biological products.